- Investing Ideas
- /
- Swiss Undervalued Stocks Based On Cash Flows
Swiss Undervalued Stocks Based On Cash Flows
Results
18
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
18 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
COTN | CHF 345.50 | 0.3% | 52.1% | CHF 2.7b | CHF 391.33 | PE153.4x | E48.3% | 0.3% | Tech | ||
SQN | CHF 302.40 | -1.3% | 72.9% | CHF 4.5b | CHF 308.60 | PE17.6x | E13.1% | 1.4% | Diversified Financials | ||
EMMN | CHF 877.00 | -1.0% | -6.1% | CHF 4.7b | CHF 1,000.25 | PE24.3x | E15.3% | 1.8% | Food, Beverage & Tobacco | ||
GF | CHF 66.55 | 2.1% | 16.1% | CHF 5.5b | CHF 75.50 | PE26.1x | E23.0% | 2.0% | Capital Goods | ||
CLN | CHF 13.40 | 2.8% | -9.1% | CHF 4.4b | CHF 16.01 | PE37.3x | E30.2% | 3.1% | Materials | ||
SGSN | CHF 94.64 | 0.4% | 17.3% | CHF 17.6b | CHF 92.02 | PE32.2x | E12.3% | 3.4% | Commercial Services | ||
LMN | CHF 19.50 | -1.7% | -16.7% | CHF 208.3m | CHF 25.98 | PE23.1x | E30.0% | 2.9% | Consumer Services | ||
LEHN | CHF 1,244.00 | -0.8% | -37.6% | CHF 1.4b | CHF 1,609.50 | PE28.6x | E18.4% | 4.0% | Tech | ||
DAE | CHF 177.60 | 2.8% | -0.7% | CHF 3.0b | CHF 182.00 | PE41.2x | E23.8% | 1.8% | Capital Goods | ||
SWON | CHF 16.00 | 0.4% | -9.7% | CHF 2.5b | CHF 18.00 | PE158.2x | E52.3% | 2.3% | Tech | ||
SENS | CHF 67.10 | -3.2% | -13.6% | CHF 1.0b | CHF 79.17 | PS4.4x | E104.7% | n/a | Tech | ||
TEMN | CHF 58.90 | 0.2% | -16.2% | CHF 4.3b | CHF 64.03 | PE37.3x | E14.3% | 1.9% | Software | ||
YPSN | CHF 415.00 | 2.2% | 66.0% | CHF 5.7b | CHF 426.20 | PE72.3x | E33.3% | 0.5% | Healthcare | ||
VACN | CHF 443.50 | 1.7% | 25.1% | CHF 13.3b | CHF 485.00 | PE66.4x | E22.5% | 1.4% | Capital Goods | ||
UBXN | CHF 79.30 | 1.3% | 0.5% | CHF 584.2m | CHF 80.00 | PS1.6x | E108.3% | 1.3% | Semiconductors | ||
SKAN | CHF 79.60 | -0.5% | 0.3% | CHF 1.8b | CHF 97.50 | PE55.5x | E20.1% | 0.4% | Pharmaceuticals & Biotech | ||
ZEHN | CHF 53.10 | -1.8% | -6.5% | CHF 579.4m | CHF 66.55 | PE27x | E32.6% | 2.3% | Capital Goods | ||
STMN | CHF 125.40 | -0.9% | -6.3% | CHF 20.0b | CHF 134.83 | PE69.5x | E21.8% | 0.7% | Healthcare |
Page 1 of 1